DELGOCITINIB

DELGOCITINIB was reported 269 times

These side effects are most commonly reported by patients taking DELGOCITINIB:

# Side effect Count
0 PRODUCT USE IN UNAPPROVED INDICATION 58
1 PRURITUS 30
2 DERMATITIS ATOPIC 25
3 DRUG INEFFECTIVE 22
4 DERMATITIS 21
5 ERYTHEMA 20
6 RASH 17
7 BURNING SENSATION 13
8 DRY SKIN 13
9 ECZEMA 13
10 SKIN BURNING SENSATION 10
11 SKIN EXFOLIATION 10
12 OFF LABEL USE 9
13 ERYTHEMA MULTIFORME 8
14 CONDITION AGGRAVATED 6
15 HEADACHE 6
16 HERPES ZOSTER 6
17 INJECTION SITE PAIN 6
18 PRODUCT DOSE OMISSION ISSUE 6
19 CELLULITIS 5
20 DYSHIDROTIC ECZEMA 5
21 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5
22 PEMPHIGOID 5
23 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5
24 SKIN FISSURES 5
25 ADVERSE DRUG REACTION 4
26 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4
27 ECZEMA HERPETICUM 4
28 INJECTION SITE SWELLING 4
29 MALAISE 4
30 PYREXIA 4
31 RASH ERYTHEMATOUS 4
32 URTICARIA 4
33 ADVERSE EVENT 3
34 ANXIETY 3
35 CUTANEOUS T-CELL LYMPHOMA 3
36 INJECTION SITE ERYTHEMA 3
37 OROPHARYNGEAL PAIN 3
38 PAIN 3
39 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3
40 RASH PRURITIC 3
41 SKIN EROSION 3
42 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3
43 THERAPEUTIC RESPONSE DECREASED 3
44 URINARY TRACT INFECTION 3
45 VISION BLURRED 3
46 APPLICATION SITE ERYTHEMA 2
47 APPLICATION SITE PAIN 2
48 APPLICATION SITE PRURITUS 2
49 APPLICATION SITE SCAB 2
50 ARTHRALGIA 2
51 BLISTER 2
52 CONJUNCTIVITIS 2
53 DERMATITIS EXFOLIATIVE GENERALISED 2
54 DIARRHOEA 2
55 DIZZINESS 2
56 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2
57 DRUG ERUPTION 2
58 DYSPNOEA 2
59 FATIGUE 2
60 FUNGAL INFECTION 2
61 GENERALISED PUSTULAR PSORIASIS 2
62 HAND DERMATITIS 2
63 HERPES SIMPLEX 2
64 HYPOAESTHESIA 2
65 HYPOGLYCAEMIA 2
66 IMPETIGO 2
67 INCORRECT DOSE ADMINISTERED 2
68 INJECTION SITE BRUISING 2
69 LOCALISED INFECTION 2
70 MUSCULAR WEAKNESS 2
71 NASAL CONGESTION 2
72 NAUSEA 2
73 NEOPLASM MALIGNANT 2
74 PARAESTHESIA 2
75 PERIPHERAL SWELLING 2
76 PRODUCT PRESCRIBING ERROR 2
77 PSORIASIS 2
78 PUSTULE 2
79 SKIN SWELLING 2
80 SLEEP DISORDER 2
81 STRESS 2
82 SWELLING 2
83 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
84 THERAPEUTIC RESPONSE SHORTENED 2
85 ABDOMINAL PAIN 1
86 ACCIDENTAL EXPOSURE TO PRODUCT 1
87 ACCIDENTAL OVERDOSE 1
88 ACETONAEMIC VOMITING 1
89 ACNE 1
90 ACQUIRED EPIDERMOLYSIS BULLOSA 1
91 ACTIVITIES OF DAILY LIVING DECREASED 1
92 ADMINISTRATION SITE IRRITATION 1
93 ADULT T-CELL LYMPHOMA/LEUKAEMIA 1
94 ADULT T-CELL LYMPHOMA/LEUKAEMIA RECURRENT 1
95 ALOPECIA AREATA 1
96 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 1
97 ANOGENITAL WARTS 1
98 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1
99 AORTIC ANEURYSM 1
100 APHONIA 1
101 APPENDICITIS 1
102 APPLICATION SITE ACNE 1
103 APPLICATION SITE DISCOLOURATION 1
104 APPLICATION SITE EROSION 1
105 APPLICATION SITE EXFOLIATION 1
106 APPLICATION SITE HYPOAESTHESIA 1
107 APPLICATION SITE INFECTION 1
108 APPLICATION SITE OEDEMA 1
109 APPLICATION SITE PAPULES 1
110 APPLICATION SITE SWELLING 1
111 APPLICATION SITE VESICLES 1
112 ARTHRITIS 1
113 ASTHMA 1
114 ATOPIC KERATOCONJUNCTIVITIS 1
115 ATRIAL FIBRILLATION 1
116 BACK DISORDER 1
117 BACTERIAL INFECTION 1
118 BENIGN BREAST NEOPLASM 1
119 BLADDER CANCER 1
120 BLEPHARITIS 1
121 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
122 BULLOUS IMPETIGO 1
123 CANDIDA INFECTION 1
124 CARDIAC FAILURE 1
125 CATARACT 1
126 CEREBROVASCULAR ACCIDENT 1
127 CEREBROVASCULAR ARTERIOVENOUS MALFORMATION 1
128 CHILLS 1
129 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
130 COLITIS ULCERATIVE 1
131 CONJUNCTIVAL HYPERAEMIA 1
132 CONJUNCTIVAL PAPILLAE 1
133 CONJUNCTIVITIS ALLERGIC 1
134 CORNEAL DISORDER 1
135 CORNEAL PERFORATION 1
136 COUGH 1
137 COVID-19 1
138 CUTANEOUS SYMPTOM 1
139 CYCLIC VOMITING SYNDROME 1
140 DEFECT CONDUCTION INTRAVENTRICULAR 1
141 DEHYDRATION 1
142 DERMATITIS ACNEIFORM 1
143 DERMATITIS CONTACT 1
144 DERMATOPHYTOSIS OF NAIL 1
145 DEVICE ISSUE 1
146 DEVICE MALFUNCTION 1
147 DIABETES MELLITUS 1
148 DISSEMINATED CRYPTOCOCCOSIS 1
149 DRUG EFFECT LESS THAN EXPECTED 1
150 DRUG HYPERSENSITIVITY 1
151 DRY MOUTH 1
152 EAR PRURITUS 1
153 ECZEMA NUMMULAR 1
154 ENTEROCOLITIS 1
155 EOSINOPHIL PERCENTAGE INCREASED 1
156 EOSINOPHILIC PNEUMONIA 1
157 EPILEPSY 1
158 ERYTHEMA NODOSUM 1
159 EYE DISORDER 1
160 EYE MOVEMENT DISORDER 1
161 EYE PRURITUS 1
162 FEBRILE NEUTROPENIA 1
163 FOLLICULAR LYMPHOMA 1
164 GASTROENTERITIS VIRAL 1
165 GENERALISED OEDEMA 1
166 GLAUCOMA 1
167 GLOMERULONEPHRITIS 1
168 GRAVES^ DISEASE 1
169 HAEMATOCHEZIA 1
170 HAEMORRHAGE 1
171 HAND-FOOT-AND-MOUTH DISEASE 1
172 HELMINTHIC INFECTION 1
173 HEPATIC CYST 1
174 HERPES OPHTHALMIC 1
175 HERPES SIMPLEX REACTIVATION 1
176 HERPES ZOSTER MENINGITIS 1
177 HIATUS HERNIA 1
178 HYDROCELE 1
179 HYPERSENSITIVITY 1
180 IDIOPATHIC URTICARIA 1
181 ILLNESS 1
182 IMMUNODEFICIENCY 1
183 INFECTION 1
184 INFECTION SUSCEPTIBILITY INCREASED 1
185 INFLAMMATION 1
186 INJECTION SITE DISCOLOURATION 1
187 INJECTION SITE HYPERSENSITIVITY 1
188 INJECTION SITE INDURATION 1
189 INJECTION SITE NODULE 1
190 INJECTION SITE PRURITUS 1
191 INSOMNIA 1
192 INTENTIONAL PRODUCT MISUSE 1
193 INTERSTITIAL LUNG DISEASE 1
194 IRON DEFICIENCY ANAEMIA 1
195 LACRIMATION INCREASED 1
196 LARGE INTESTINE POLYP 1
197 LICHENIFICATION 1
198 LIMB DISCOMFORT 1
199 LIP OEDEMA 1
200 LOWER RESPIRATORY TRACT INFECTION 1
201 LUNG OPACITY 1
202 LYMPHANGITIS 1
203 LYMPHOCYTE MORPHOLOGY ABNORMAL 1
204 MACULAR HOLE 1
205 MEDIAN NERVE INJURY 1
206 MENINGITIS 1
207 MOLLUSCUM CONTAGIOSUM 1
208 MONOPARESIS 1
209 MONOPLEGIA 1
210 MYALGIA 1
211 MYDRIASIS 1
212 MYELITIS 1
213 MYOCARDIAL INFARCTION 1
214 NAIL DYSTROPHY 1
215 NASOPHARYNGITIS 1
216 NEPHROTIC SYNDROME 1
217 NEUROSYPHILIS 1
218 OCULAR SURFACE DISEASE 1
219 OEDEMA 1
220 OEDEMA PERIPHERAL 1
221 ONYCHOLYSIS 1
222 OROPHARYNGEAL OEDEMA 1
223 PAIN OF SKIN 1
224 PALLOR 1
225 PALMOPLANTAR PUSTULOSIS 1
226 PAPULE 1
227 PARONYCHIA 1
228 PETECHIAE 1
229 PLEURAL EFFUSION 1
230 PNEUMONIA STREPTOCOCCAL 1
231 PRODUCT RESIDUE PRESENT 1
232 PROTEINURIA 1
233 RASH MACULAR 1
234 RASH PAPULAR 1
235 RENAL IMPAIRMENT 1
236 RHINITIS 1
237 RHINORRHOEA 1
238 SCAB 1
239 SKIN HYPERPIGMENTATION 1
240 SKIN IRRITATION 1
241 SKIN REACTION 1
242 SKIN ULCER 1
243 STAPHYLOCOCCAL BACTERAEMIA 1
244 STRABISMUS 1
245 SUBARACHNOID HAEMORRHAGE 1
246 TENDON RUPTURE 1
247 TENOPLASTY 1
248 TENSION HEADACHE 1
249 THERAPEUTIC PRODUCT EFFECT DECREASED 1
250 THERAPEUTIC RESPONSE UNEXPECTED 1
251 THERAPY CESSATION 1
252 THROMBOSIS 1
253 TONGUE OEDEMA 1
254 TOOTH LOSS 1
255 TRANSPLANT REJECTION 1
256 TREATMENT FAILURE 1
257 UPPER RESPIRATORY TRACT INFECTION 1
258 UVEITIS 1
259 VARICELLA 1
260 VIRAL INFECTION 1
261 VIRAL UPPER RESPIRATORY TRACT INFECTION 1
262 VISUAL IMPAIRMENT 1
263 VOMITING 1
264 VULVOVAGINAL ERYTHEMA 1
265 WEIGHT INCREASED 1
266 WHITE BLOOD CELL COUNT INCREASED 1